Caricamento...
Oral atenolol therapy for proliferating infantile hemangioma: A prospective study
Propranolol, a lipophilic nonselective β-blocker, has recently been reported to be the treatment of choice for select types of infantile hemangiomas (IHs). Atenolol is a hydrophilic, selective β(1)-blocker and therefore may be not associated with side effects attributable to β(2)-adrenergic receptor...
Salvato in:
| Pubblicato in: | Medicine (Baltimore) |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer Health
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4998480/ https://ncbi.nlm.nih.gov/pubmed/27310994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000003908 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|